During the past decade, OSF Saint Francis Radiation Oncology at Peoria Cancer Center conducted 100 clinical trials. In the 10-year time frame, 100 clinical trials started and 82 clinical trials were completed, i.e. on average, 82% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 62 clinical trials were completed. i.e. 295.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "OSF Saint Francis Radiation Oncology at Peoria Cancer Center" #1 sponsor was "National Cancer Institute (NCI)" with 73 trials, followed by "SWOG Cancer Research Network" with 27 trials sponsored, "Alliance for Clinical Trials in Oncology" with 24 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 11 trials sponsored and "NRG Oncology" with 11 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "OSF Saint Francis Radiation Oncology at Peoria Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 89 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 9 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "OSF Saint Francis Radiation Oncology at Peoria Cancer Center" are "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (7 trials), "Recurrent Ovarian Carcinoma" (6 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "OSF Saint Francis Radiation Oncology at Peoria Cancer Center" in a lesser frequency.

Most popular intervention types in "OSF Saint Francis Radiation Oncology at Peoria Cancer Center" are "Drug" (128 trials), "Other" (107 trials), "Biological" (60 trials), "Radiation" (44 trials) and "Procedure" (33 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (64 trials), "Quality-of-Life Assessment" (36 trials), "Cisplatin" (28 trials), "Carboplatin" (22 trials) and "Questionnaire Administration" (20 trials). Other intervention names were less common.

The vast majority of trials in "OSF Saint Francis Radiation Oncology at Peoria Cancer Center" are 126 trials for "All" genders, 29 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "OSF Saint Francis Radiation Oncology at Peoria Cancer Center". undefined are not yet recruiting, 28 are recruiting, 83 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 36 completed trials in OSF Saint Francis Radiation Oncology at Peoria Cancer Center, 4 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in OSF Saint Francis Radiation Oncology at Peoria Cancer Center, 11 "Phase 1" clinical trials were conducted, 78 "Phase 2" clinical trials and 88 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".